Literature DB >> 21892719

Clinical applications of dynamic susceptibility contrast perfusion-weighted MR imaging in brain tumours.

A Romano1, M C Rossi Espagnet, L F Calabria, V Coppola, L Figà Talamanca, V Cipriani, G Minniti, A Pierallini, L M Fantozzi, A Bozzao.   

Abstract

Magnetic resonance imaging (MRI) with a dynamic susceptibility contrast perfusion-weighted imaging (DSC-PWI) sequence to study brain tumours provides information on the haemodynamic characteristics of the neoplastic tissue. Brain perfusion maps and calculation of perfusion parameters, such as relative cerebral blood flow (rCBF), relative cerebral blood volume (rCBV) and mean transit time (MTT) allow assessment of vascularity and angiogenesis within tumours of the central nervous system (CNS), thus providing additional information to conventional MRI sequences. Although DSC-PWI has long been used, its clinical use in the study of brain tumours in daily clinical practice is still to be defined. The aim of this review was to analyse the application of perfusion MRI in the study of brain tumours by summarising our personal experience and the main results reported in the literature.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21892719     DOI： 10.1007/s11547-011-0715-4

Source DB:  PubMed          Journal:  Radiol Med        ISSN： 0033-8362            Impact factor:   3.469


  37 in total

Review 1.  Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging.

Authors:  Soonmee Cha; Edmond A Knopp; Glyn Johnson; Stephan G Wetzel; Andrew W Litt; David Zagzag
Journal:  Radiology       Date:  2002-04       Impact factor: 11.105

2.  Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements.

Authors:  L S Hu; L C Baxter; K A Smith; B G Feuerstein; J P Karis; J M Eschbacher; S W Coons; P Nakaji; R F Yeh; J Debbins; J E Heiserman
Journal:  AJNR Am J Neuroradiol       Date:  2008-12-04       Impact factor: 3.825

3.  Dynamic susceptibility-weighted perfusion imaging of high-grade gliomas: characterization of spatial heterogeneity.

Authors:  Janine M Lupo; Soonmee Cha; Susan M Chang; Sarah J Nelson
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

4.  Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging.

Authors:  Bahattin Hakyemez; Cuneyt Erdogan; Naile Bolca; Nalan Yildirim; Gokhan Gokalp; Mufit Parlak
Journal:  J Magn Reson Imaging       Date:  2006-10       Impact factor: 4.813

5.  Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas.

Authors:  R G Henry; D B Vigneron; N J Fischbein; P E Grant; M R Day; S M Noworolski; J M Star-Lack; L L Wald; W P Dillon; S M Chang; S J Nelson
Journal:  AJNR Am J Neuroradiol       Date:  2000-02       Impact factor: 3.825

6.  Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].

Authors:  Michael H Lev; Yelda Ozsunar; John W Henson; Amjad A Rasheed; Glenn D Barest; Griffith R Harsh; Markus M Fitzek; E Antonio Chiocca; James D Rabinov; Andrew N Csavoy; Bruce R Rosen; Fred H Hochberg; Pamela W Schaefer; R Gilberto Gonzalez
Journal:  AJNR Am J Neuroradiol       Date:  2004-02       Impact factor: 3.825

7.  Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.

Authors:  T Sugahara; Y Korogi; M Kochi; I Ikushima; T Hirai; T Okuda; Y Shigematsu; L Liang; Y Ge; Y Ushio; M Takahashi
Journal:  AJR Am J Roentgenol       Date:  1998-12       Impact factor: 3.959

8.  Contribution of dynamic contrast MR imaging to the differentiation between dural metastasis and meningioma.

Authors:  S Kremer; S Grand; C Rémy; B Pasquier; A L Benabid; S Bracard; J F Le Bas
Journal:  Neuroradiology       Date:  2004-06-30       Impact factor: 2.804

9.  Relative cerebral blood volume measurements of low-grade gliomas predict patient outcome in a multi-institution setting.

Authors:  Gisele B Caseiras; Sophie Chheang; James Babb; Jeremy H Rees; Nicole Pecerrelli; Daniel J Tozer; Christopher Benton; David Zagzag; Glyn Johnson; Adam D Waldman; H R Jäger; Meng Law
Journal:  Eur J Radiol       Date:  2009-02-06       Impact factor: 3.528

10.  Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation?

Authors:  Nasuda Danchaivijitr; Adam D Waldman; Daniel J Tozer; Christopher E Benton; Gisele Brasil Caseiras; Paul S Tofts; Jeremy H Rees; H Rolf Jäger
Journal:  Radiology       Date:  2008-04       Impact factor: 11.105
View more
  8 in total

1.  Recurrent glioblastoma multiforme versus radiation injury: a multiparametric 3-T MR approach.

Authors:  Alfonso Di Costanzo; Tommaso Scarabino; Francesca Trojsi; Teresa Popolizio; Simona Bonavita; Mario de Cristofaro; Renata Conforti; Adriana Cristofano; Claudio Colonnese; Ugo Salvolini; Gioacchino Tedeschi
Journal:  Radiol Med       Date:  2014-01-10       Impact factor: 3.469

2.  Dynamic susceptibility contrast (DSC) perfusion MRI in differential diagnosis between radionecrosis and neoangiogenesis in cerebral metastases using rCBV, rCBF and K2.

Authors:  Mario Muto; Giulia Frauenfelder; Rossana Senese; Fabio Zeccolini; Emiliano Schena; Francesco Giurazza; Hans Rolf Jäger
Journal:  Radiol Med       Date:  2018-03-05       Impact factor: 3.469

3.  Measurement of arteriolar blood volume in brain tumors using MRI without exogenous contrast agent administration at 7T.

Authors:  Yuankui Wu; Shruti Agarwal; Craig K Jones; Andrew G Webb; Peter C M van Zijl; Jun Hua; Jay J Pillai
Journal:  J Magn Reson Imaging       Date:  2016-03-30       Impact factor: 4.813

4.  Advanced neuroimaging in the clinic: critical appraisal of the evidence base.

Authors:  Adam Z Fink; Lisa B Mogil; Michael L Lipton
Journal:  Br J Radiol       Date:  2016-05-05       Impact factor: 3.039

5.  Astrocytic tumour grading: a comparative study of three-dimensional pseudocontinuous arterial spin labelling, dynamic susceptibility contrast-enhanced perfusion-weighted imaging, and diffusion-weighted imaging.

Authors:  Hua-Feng Xiao; Zhi-Ye Chen; Xin Lou; Yu-Lin Wang; Qiu-Ping Gui; Yan Wang; Kai-Ning Shi; Zhen-Yu Zhou; Dan-Dan Zheng; Danny J J Wang; Lin Ma
Journal:  Eur Radiol       Date:  2015-05-23       Impact factor: 5.315

6.  Additive antiangiogenesis effect of ginsenoside Rg3 with low-dose metronomic temozolomide on rat glioma cells both in vivo and in vitro.

Authors:  Caixing Sun; Yang Yu; Lizhen Wang; Bin Wu; Liang Xia; Fang Feng; Zhiqiang Ling; Shihua Wang
Journal:  J Exp Clin Cancer Res       Date:  2016-02-13

Review 7.  Advanced MRI for Pediatric Brain Tumors with Emphasis on Clinical Benefits.

Authors:  Hyun Woo Goo; Young-Shin Ra
Journal:  Korean J Radiol       Date:  2017-01-05       Impact factor: 3.500

8.  Differentiating solitary brain metastases from high-grade gliomas with MR: comparing qualitative versus quantitative diagnostic strategies.

Authors:  Ioan Paul Voicu; Emanuele Pravatà; Valentina Panara; Riccardo Navarra; Peter A Mattei; Massimo Caulo
Journal:  Radiol Med       Date:  2022-06-28       Impact factor: 6.313
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.